BioAtla, Inc.
6 clinical trials · Sponsor
| Record | Firm | Date |
|---|---|---|
| Phase 1 Study Evaluating BA3182 in Patients With Advanced Adenocarcinoma. (NCT05808634) | BioAtla, Inc. | 2023-07-14 |
| A Phase 2 Open Label Study of BA3021 in Patients With Recurrent or Metastatic Squamous Cell Carcinoma of the Head and Neck (NCT05271604) | BioAtla, Inc. | 2022-12-13 |
| A Phase 1/2 Study of BA3071 in Patients With Solid Tumors (NCT05180799) | BioAtla, Inc. | 2022-08-03 |
| CAB-AXL-ADC Safety and Efficacy Study in Adults With NSCLC (NCT04681131) | BioAtla, Inc. | 2021-03-17 |
| CAB-ROR2-ADC Safety and Efficacy Study in Patients With TNBC or Head & Neck Cancer (Ph1) and NSCLC or Melanoma (Ph2) (NCT03504488) | BioAtla, Inc. | 2018-06-27 |
Track BioAtla, Inc. automatically
Every clearance here is in the API, with alerts when new ones post.